Skandinaviska Enskilda Banken Ab (Publ) Twist Bioscience Corp Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$33.44 - $56.56 $577,776 - $977,243	-17,278 Reduced 61.77%	10,692 $377,000
Q2 2022 Aug 10, 2022	BUY	$26.2 - $54.0 $452,683 - $933,012	17,278 Added 161.6%	27,970 $978,000
Q4 2021 Feb 10, 2022	SELL	$75.47 - $135.88 $123,544 - $222,435	-1,637 Reduced 13.28%	10,692 $840,000
Q2 2021 Aug 10, 2021	BUY	$88.13 - $142.06 $1.09 Million - $1.75 Million	12,329 New	12,329 $1.64 Million
Q1 2021 May 14, 2021	SELL	$105.48 - $207.97 $10,548 - $20,797	-100 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$76.64 - $167.89 $283,568 - $621,193	-3,700 Reduced 97.37%	100 $14,000
Q3 2020 Nov 12, 2020	BUY	$45.46 - $78.79 $172,748 - $299,402	3,800 New	3,800 $289,000

256

66.6M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.68B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.